Roche Diagnostics Limited Product Pipeline Analysis

Publication Date	August 2008
Publisher	Global Markets Direct
Product Type	Report
Pages	42
ISBN Number	not applicable
Product Code	GMD04700

Price

£515.00
approximately: $750 | €594

PDF

Order above formats by FAX

Summary

This report is an insightful source for data, analysis and strategic insights into a Roche Diagnostics Limited's pipeline and investigational products. The report also provides details on clinical trials covering trial phase, description, investigator information, primary and secondary end-points and trial results for products in development.

Scope

Details of development stage by sector and equipment type.
Pipeline products grouped by therapy area, development stage and trial phase.
Detailed information on clinical trials covering trial phase, description, investigator .nformation, primary and secondary end-points and trial results.
Trial updates, trial start and end dates, patient numbers and the trials primary outcome measures, secondary outcome measures.
Product updates covering estimated approval dates and estimated launch dates.
Descriptions of novel technologies relating to pipeline products of the company.
Patents and patent applications covered for the product.
News updates on key events relating to the product and its development.

Reasons to buy

A single source to fulfill competitor information relating to products in development.
Identify pipeline products that are potential competitor to your product lines.

Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline.

Access clinical trial information to map trial results and plan targeted marketing activities.
Take corrective measures on your own development programs and R&D initiatives based on regulatory events of competitor product pipelines.
Identification of potential investment opportunities.
Build up knowledge base for potential distribution and marketing partners.
Helps avoid patent infringement.
Timelines from concept to market lets you keep track of market potential build for a new product.

Assess a company's future growth by determining its pipeline depth, for probable acquisition opportunities.

Content

1.1 List Of Tables
1.2 List of Figures
2 Company Overview
2.1 Key Information
2.2 Financial Performance
2.3 Industry Outlook Diagnostic Imaging
2.4 Industry Outlook In Vitro Diagnostics
3 Major Products and Services
3.1 Overview
4 Competitors
5 Locations And Subsidiaries
5.1 Head Office
6 Recent Developments
6.1 Product News
- 6.1.1 Jul 01, 2008: Study Reveals Potential For NT-proBNP As A Marker To Predict Cardiovascular Risks From Anti-inflammatory Drugs
- 6.1.2 Jun 15, 2008: Roche Chlamydia Test Approved In Europe
- 6.1.3 Apr 17, 2008: Molecular Diagnostics Continued Growth In Virology
- 6.1.4 Apr 08, 2008: Roche Diagnostics Expands Availability Of HCV Immunoassay
- 6.1.5 Apr 03, 2008: Roche Applied Science Selects The Technology Of NuGEN WT-Ovation As RNA Amplification Product For LightCycler System
- 6.1.6 Mar 27, 2008: Roche Diagnostics Launches First Fully-Automated TSH Receptor Antibody Assay
- 6.1.7 Mar 18, 2008: ACCU-CHEK Aviva system Receives Arthritis Foundation's Ease-of-Use Commendation
- 6.1.8 Feb 18, 2008: Mankind Pharma To Market Roche's Accu-Chek Go in India
- 6.1.9 Aug 29, 2007: FDA Approves New Roche West Nile Virus Blood Screening Test
- 6.1.10 Mar 08, 2007: FDA Accepts For Review New Roche Diagnostics Blood Screening Test
- 6.1.11 Jan 18, 2007: Roche Diagnostics Submits West Nile Virus Blood Screening Test To FDA
- 6.1.12 Mar 07, 2006: New Test For Improved Detection Of HIV And Hepatitis Viruses In Donated Blood Receives CE Mark Certification
- 6.1.13 Jul 03, 2003: Clinical Trial Site Using Roche's TaqScreen West Nile Virus Test Intercepts First Unit Of Infected Blood
6.2 Product Approvals
- 6.2.1 Jun 15, 2008: Roche Chlamydia Test Approved In Europe
- 6.2.2 Apr 08, 2008: Roche Diagnostics Expands Availability Of HCV Immunoassay
- 6.2.3 Aug 29, 2007: FDA Approves New Roche West Nile Virus Blood Screening Test
- 6.2.4 Mar 07, 2006: New Test For Improved Detection Of HIV And Hepatitis Viruses In Donated Blood Receives CE Mark Certification
6.3 Clinical Trials
- 6.3.1 Jul 01, 2008: Study Reveals Potential For NT-proBNP As A Marker To Predict Cardiovascular Risks From Anti-inflammatory Drugs
- 6.3.2 Jul 03, 2003: Clinical Trial Site Using Roche's TaqScreen West Nile Virus Test Intercepts First Unit Of Infected Blood
6.4 Other Significant Developments
- 6.4.1 Dec 20, 2007: Home Diagnostics Reaches Settlement Agreement With Roche
- 6.4.2 Jun 15, 2007: Sysmex Extends Distribution Agreement With Roche
7 Roche Diagnostics Limited Pipeline Products
7.1 Roche Diagnostics Limited Product Pipeline Analysis
- 7.1.1 Roche Diagnostics Limited Pipeline Products By Equipment Type
- 7.1.2 Roche Diagnostics Limited Pipeline Products By Development Stage
- 7.1.3 Roche Diagnostics Limited Pipeline Products By Therapy Area
- 7.1.4 Roche Diagnostics Limited Pipeline Products By Clinical Trials
- 7.1.5 Roche Diagnostics Limited Pipeline Products By News Summary
7.2 Multiplex assay for HIV, HBV and HCV
- 7.2.1 Product Description
- 7.2.2 Product Status
7.3 Test for human papillomavirus
- 7.3.1 Product Description
- 7.3.2 Product Status
7.4 Microarray-based Oncology Test-Leukemia
- 7.4.1 Product Description
- 7.4.2 Product Status
7.5 Cobas TaqScreen West Nile Virus Test
- 7.5.1 Product Description
- 7.5.2 Product Status
- 7.5.3 Product Milestone
7.6 Microarray-based Oncology Test- Lymphoma
- 7.6.1 Product Description
- 7.6.2 Product Status
7.7 Microarray-based Oncology Test- p53 Tumour Suppressor
- 7.7.1 Product Description
- 7.7.2 Product Status
7.8 LightCycler RNA Pre-Amplification Kit
- 7.8.1 Product Description
- 7.8.2 Product Status
- 7.8.3 Product Milestone
7.9 HCV test
- 7.9.1 Product Description
- 7.9.2 Product Status
- 7.9.3 Product Milestone
- 7.9.4 Product Patent Details
7.10 Automated pancreas
- 7.10.1 Product Description
- 7.10.2 Product Status
7.11 Elecsys NT-proBNP assay-Second-generation version
- 7.11.1 Product Description
- 7.11.2 Product Status
7.12 Cobas TaqScreen MPX Test
- 7.12.1 Product Description
- 7.12.2 Product Status
- 7.12.3 Clinical Trials
- 7.12.4 Product Milestone
7.13 CoaguChek S
- 7.13.1 Product Description
- 7.13.2 Product Status
- 7.13.3 Clinical Trials
7.14 ELECSYS test kit
- 7.14.1 Product Description
- 7.14.2 Product Status
8 Appendix
8.1 Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Expert Panel Validation
8.2 Contact Us
8.3 About Global Markets Direct
8.4 Disclaimer
1.1 List Of Tables
Table 1: Roche Diagnostics Limited,Key Facts
Table 2: Roche Diagnostics Limited Pipeline Products by Equipment Type
Table 3: Roche Diagnostics Limited Pipeline Products By Development Stage
Table 4: Roche Diagnostics Limited Pipeline Products By Therapy Area
Table 5: Roche Diagnostics Limited Pipeline Products By Clinical Trials
Table 6: Roche Diagnostics Limited Pipeline Products By News Summaries
1.2 List of Figures
Figure 1: Roche Diagnostics Limited Pipeline Products By Equipment Type
Figure 2: Roche Diagnostics Limited Pipeline Products By Equipment Type
Figure 3: Roche Diagnostics Limited Pipeline Products By Development Stage
Figure 4: Roche Diagnostics Limited Pipeline Products By News Summary
Figure 5: Global Markets Direct Methodology